Document is current
Any future updates will be listed below
-
Authors
Sigaud, Romain https://orcid.org/0000-0002-8600-8876
Stefanski, Anja
Selt, Florian
Kocher, Daniela https://orcid.org/0009-0007-0235-1081
Usta, Diren
Picard, Daniel
Büdenbender, Isabel
Remke, Marc
Pfister, Stefan M. https://orcid.org/0000-0002-5447-5322
Jones, David T. W. https://orcid.org/0000-0002-2036-5141
Brummer, Tilman https://orcid.org/0000-0003-4387-7905
Witt, Olaf
Milde, Till https://orcid.org/0000-0002-7267-1052
-
Funding
Funding for this research was provided by:
Friedrich-Ebert-Stiftung
Brain Tumour Charity (GN-000707, GN-000707, GN-000707)
Deutsche Forschungsgemeinschaft (BR 3662/5–1, SFB-1479 Oncoescape - 441891347 (P14))
DKTK JF Upgrade Next Gen LOGGIC
- License Information
-
More Information
Article History
Received: 6 November 2024
Revised: 5 May 2025
Accepted: 20 May 2025
First Online: 23 June 2025
Competing interests
: O.W. and T.M. were supported by research grants from Biomed Valley Discoveries, Inc., and Day One Biopharmaceuticals. TB received honoraria from Pierre Fabre and the European Society for Medical Oncology (ESMO). The remaining authors declare no competing interests.
